{"In": [0, 206], "March": [1], "2020,": [2], "the": [3, 44, 97, 103, 132, 148, 211], "World": [4], "Health": [5], "Organization": [6], "(WHO)": [7], "declared": [8], "coronavirus": [9, 21], "disease": [10], "2019": [11], "(COVID-19),": [12], "which": [13, 184], "is": [14, 38, 89], "caused": [15], "by": [16, 76], "severe": [17], "acute": [18], "respiratory": [19], "syndrome": [20], "2": [22, 74], "(SARS-CoV-2)1,": [23], "a": [24, 36, 90, 136, 143, 166, 177, 192, 207, 235], "pandemic.": [25], "With": [26], "rapidly": [27], "accumulating": [28], "numbers": [29], "of": [30, 67, 86, 102, 106, 131, 138, 176, 179, 201, 210], "cases": [31], "and": [32, 48, 110, 119, 135, 154, 164, 223, 233], "deaths": [33], "reported": [34], "globally2,": [35], "vaccine": [37, 94, 204, 214, 237], "urgently": [39], "needed.": [40], "Here": [41], "we": [42], "report": [43], "available": [45], "safety,": [46], "tolerability": [47], "immunogenicity": [49, 141], "data": [50], "from": [51], "an": [52], "ongoing": [53], "placebo-controlled,": [54], "observer-blinded": [55], "dose-escalation": [56, 208], "study": [57, 209], "(ClinicalTrials.gov": [58], "identifier": [59], "NCT04368728)": [60], "among": [61], "45": [62, 217], "healthy": [63, 218], "adults": [64], "(18\u201355": [65], "years": [66], "age),": [68], "who": [69], "were": [70, 113, 185], "randomized": [71], "to": [72, 117], "receive": [73], "doses\u2014separated": [75], "21": [77], "days\u2014of": [78], "10": [79], "\u03bcg,": [80], "30": [81], "\u03bcg": [82, 85, 126], "or": [83], "100": [84, 125], "BNT162b1.": [87], "BNT162b1": [88, 215], "lipid-nanoparticle-formulated,": [91], "nucleoside-modified": [92], "mRNA": [93, 203], "that": [95, 175], "encodes": [96], "trimerized": [98], "receptor-binding": [99], "domain": [100], "(RBD)": [101], "spike": [104], "glycoprotein": [105], "SARS-CoV-2.": [107], "Local": [108], "reactions": [109], "systemic": [111], "events": [112], "dose-dependent,": [114], "generally": [115], "mild": [116], "moderate,": [118], "transient.": [120], "A": [121], "second": [122, 167, 236], "vaccination": [123], "with": [124, 147, 161, 230], "was": [127], "not": [128], "administered": [129], "because": [130], "increased": [133, 140, 160, 229], "reactogenicity": [134], "lack": [137], "meaningfully": [139], "after": [142, 165, 191, 234], "single": [144], "dose": [145, 162, 231], "compared": [146], "30-\u03bcg": [149], "dose.": [150, 168, 238], "RBD-binding": [151, 220], "IgG": [152, 221], "concentrations": [153, 222], "SARS-CoV-2": [155, 194, 224], "neutralizing": [156, 171, 225], "titres": [157, 172, 226], "in": [158, 216, 227], "sera": [159, 228], "level": [163, 232], "Geometric": [169], "mean": [170], "reached": [173], "1.9\u20134.6-fold": [174], "panel": [178], "COVID-19": [180, 212], "convalescent": [181], "human": [182], "sera,": [183], "obtained": [186], "at": [187], "least": [188], "14": [189], "days": [190], "positive": [193], "PCR.": [195], "These": [196], "results": [197], "support": [198], "further": [199], "evaluation": [200], "this": [202], "candidate.": [205], "RNA": [213], "adults,": [219]}